AFP and hepatocellular carcinoma: The 5-year overall/DFS of HCC patients with low expression of the AFP/AFU combination was almost 60% and 40%, respectively, while the survival of patients with high expression was approximately 40% and 25%, respectively (Supplementary Figure S7C and D).